Edgewise Therapeutics (EWTX) Other Non-Current Assets (2020 - 2026)

Edgewise Therapeutics has reported Other Non-Current Assets for 6 years, with the latest figure at $695000.0 in Q1 2025.

• Quarterly Other Non-Current Assets changed N/A year-over-year to $695000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $695000.0 (changed N/A YoY) and the FY2024 annual result came in at $262000.0, down 24.71% from the prior year.
• Other Non-Current Assets rose to $695000.0 in Q1 2025 per EWTX's latest filing, from $262000.0 in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $695000.0 in Q1 2025 and troughed at $201000.0 in Q1 2021.
• A 5-year average of $368733.3 and a median of $295000.0 in 2021 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets jumped 178.11% in 2022, then sank 55.1% in 2023.
• Over 5 years, Other Non-Current Assets stood at $548000.0 in 2021, then plunged by 54.2% to $251000.0 in 2022, then surged by 38.65% to $348000.0 in 2023, then slipped by 24.71% to $262000.0 in 2024, then jumped by 165.27% to $695000.0 in 2025.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $695000.0, $262000.0, and $262000.0 for Q1 2025, Q4 2024, and Q3 2024 respectively.